Dr. Richard M. Sankary M.D.

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

Researchers have been trying to figure out why Cystic Fibrosis (CF) patients are unable to fight off bacterial infections.Recently, studying pigs have helped scientists understand CF better.Why pigs?Initially, mice were used to evaluate CF, but they did not spontaneously develop CF like humans do....

Since cystic fibrosis runs in the family, continuously researching news about the disease can help both patients and their families stay up to date on current events, such as new CF medications and treatments. Yet, for one woman, Dr. Wanda O’Neal, merely researching the latest information on CF...

Cystic fibrosis is considered incurable, and is a daily struggle for all of those who have it. Constant research is being poured into finding better treatment, and potentially even a cure, but Rowan's Public Relations Student Society of America (PRSSA) is putting their own spin (literally) on...

Lung cancer, also known as lung carcinoma is characterized by a malignant lung tumor caused by an uncontrolled growth of cells in tissues of the lungs. There are two main types of lung cancers-small cell lung cancer and non-small cell lung cancer. It is widely known that lung cancer is the most...

Moving from pediatric CF to adult CF medical care is an essential transition for young adults living with cystic fibrosis (CF). This transition period is a crucial and significant step in maintaining stable health well into adulthood. Most individuals with CF transition from pediatric CF to adult CF...